Clinical trial
Feasibility and Preliminary Effectiveness of Varenicline for Co-occurring Cannabis and Tobacco Use
NCT04595318 is registered in ClinicalTrials.gov with Albert Einstein College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility and Preliminary Effectiveness of Varenicline for Co-occurring Cannabis and Tobacco Use
- Lead sponsor
- Albert Einstein College of Medicine
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- July 31, 2015
- Enrollment
- 7 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cannabis dependence, tobacco dependence